Kamada Ltd. — Board/Management Information 2022

Jun 15, 2022

Kamada Strengthens Senior Leadership Team; Furthering Commitment as a Fully Integrated Global Leader in the Specialty Plasma Derived Therapeutics Ma false

����� ��"�	2 380
KAMADA LTD
Corporation no: 511524605	14096
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	15/06/2022
	www.isa.gov.il			www.tase.co.il				Reference:	2022-02-060876	Time of broadcast: 13:54 13:54

---

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onKamada Strengthens Senior Leadership Team; Furthering Commitment as a Fully Integrated Global Leader in the Specialty Plasma Derived Therapeutics Market

ea161623-6k_kamadaltdEDGAR1_Bannerless_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: TASE	Date of revision of form structure: 07/06/2022
Address: Holtzman 2 4081 , Rehovot 7670402   ISRAEL , Tel: 08-9406472 , Fax: 08-9406473
E-mail address: liorf@kamada.com   Company site: www.kamada.com
Previous names of reporting entity:
Name of the Signatory: REFAEL MOSHE Position of Signatory in the reporting corporation: Company Controller Name of Employer Company:
Address: Holtzman 2 , Rehovot 7670402 Telephone: 08-9406472 Facsimile: 08-9406473 E-mail: mosheb@kamada.com 1